Freestone Grove Partners’s Dillards DDS Stock Holding History

Freestone Grove Partners’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,621	Closed	-$677K	–	745
2025 Q2	$677K	Buy	+1,621	New	+$605K	0.01%	486

Other funds holding DDS

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CWM

ClientFirst Wealth Management Little Rock, Arkansas $118M AUM 40.43% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Freestone Grove Partners's DDS Position: Q3 2025 in Review

Freestone Grove Partners sold out of Dillards (DDS) in Q3 2025, closing a stake of 1,621 shares — an estimated $677K sold.

Freestone Grove Partners first reported a position in DDS in Q2 2025 and held it in 1 quarter. The position peaked at $677K in Q2 2025. 293 funds tracked by Wall St. Rank hold DDS as of Q3 2025.

Freestone Grove Partners reported no remaining Dillards position as of Q3 2025 after selling out during the quarter.
Freestone Grove Partners sold 1,621 Dillards shares in Q3 2025, an estimated $677K.
Freestone Grove Partners first reported a position in Dillards in Q2 2025 and held it in 1 quarter.
Freestone Grove Partners's Dillards position peaked at $677K in Q2 2025.
293 funds tracked by Wall St. Rank held Dillards as of Q3 2025.

Based on Freestone Grove Partners's 13F filing for Q3 2025, filed 14 Nov 2025.